Top Stocks To Watch Today? 5 Consumer Discretionary Stocks To Know

Should Investors Be Watching These Top Consumer Discretionary Stocks Now?

As investors navigate a somewhat volatile stock market with meme stocks leading in gains, consumer discretionary stocks could be overlooked. Now, as most investors would know, the economy is on the uptrend as we reach the tail-end of the pandemic. At the same time, businesses that suffered during the onslaught of the pandemic would be in the reopening trade as well. Not to mention, there is also the factor of consumers being eager to spend their discretionary funds during the summer. Given all of this, we could be looking at a perfect storm for the industry now. In fact, even the current economic data estimates appear to be in line with this.

Notably, the consumer price index (CPI) readings for May are due on Thursday later this week. Economists currently estimate that the CPI could rise by 4.7% year-over-year, indicating record figures last seen in 2008. What would all this mean for investors? Simply put, some would argue that consumers are spending heavily as more pre-pandemic services return. Moreover, consumers also have more choices than ever to do so. Because of this, consumer discretionary stocks across the board would be in a position to gain momentum. From cannabis stocks like Grow Generation (NASDAQ: GRWG) or cruise line stocks such as Royal Caribbean (NYSE: RCL), entry points are plentiful. Having read all this, you might be keen on adding some consumer discretionary stocks to your list as well. In that case, here are five making headlines in the stock market today.

Best Consumer Discretionary Stocks To Watch In June

Tilray Inc.

Starting us off today is Canadian-based cannabis giant, Tilray Inc. For some context, the company is a leading name in the global marijuana-lifestyle and consumer packaged goods market now. In terms of scale, Tilray operates in Canada, the U.S., Europe, Australia, and Latin America. Moreover, the company boasts a massive portfolio of over 20 cannabis-based brands spanning 20 countries. The likes of which include comprehensive cannabis offerings, hemp-based foods, and even alcoholic beverages. As it stands, TLRY stock closed Tuesday’s trading session at $20.22. Seeing as it is up by over 110% year-to-date, could TLRY stock have more room to grow this year?

Well, for one thing, Tilray does not appear to be slowing down anytime soon. Earlier today the company launched Symbios, its newest medical cannabis brand. According to Tilray, Symbios will serve to provide a wider array of “formats and unique cannabinoid ratios” at more affordable price points. This would include medical patients getting access to products such as dried flowers and oils among others. It appears that while the recreational cannabis market continues to expand, Tilray is not neglecting its medical portfolio as well. Would all this make TLRY stock a top buy for you now?